KBio aims to create a new generation of biologics using its plant-based platform that has demonstrated the ability to create drug candidates at a fraction of the time and cost of conventional platforms. The Company is focused on developing novel product candidates in two core areas: 1) Antibody therapies for areas of high unmet need; and 2) Pandemic preparedness and response using its plant-based production system to create antibodies and vaccines in shorter timeframes than industry norms. Formed in December 2021, KBio is a subsidiary of BAT with operations in the UK and U.S.
| Website | http://www.kbio.com |
| Employees | 39 (13 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Drug Discovery Platform, Novel Therapeutics, Accelerated Drug Development, Biotechnology Platform, Therapeutic Proteins, Biologics Manufacturing, Innovative Drug Delivery, Plant Cell Technology, Biosimilar Development, Plant Based Pharmaceuticals, Biopharmaceutical Production, Protein Production, Sustainable Biomanufacturing, Pharmaceutical Manufacturing |
| Competitors | Thermo Fisher Scientific, Merck Group, Bio-Rad Laboratories, Agilent Technologies, GE HealthCare, PerkinElmer, Inc., Roche, Illumina, QIAGEN, BD +47 more (view full list) |
Looking for a particular KBio employee's phone or email?
KBio Questions
Barry Bratcher is the CEO of KBio.
13 people are employed at KBio.
KBio is based in Owensboro, Kentucky.
Top KBio Employees
-
Barry Bratcher
Chief Executive Officer at KBio
Owensboro, KY, US15+ -
Carmine Carpenito
Head of Research at KBio
New York, NY, US44 -
Elena Federzoni
Drug Discovery and Development - Biologics at KBio
San Diego, CA, US1 -
25+
-
Katrina Whelan
Director of Quality Assurance at KBio
Owensboro, KY, US13 -
Fallin Ballard
QC and Analytical Scientist at KBio
Owensboro, KY, US1 -
Amanda Phillips
Senior Scientist at KBio
Spottsville, KY, US55 -
Michael Church
Scientist at KBio
Owensboro, KY, US11 -
Travis Newton
Senior Engineer at KBio
Owensboro, KY, US23
Related Companies
